Table of Contents Author Guidelines Submit a Manuscript
International Journal of Endocrinology
Volume 2011, Article ID 707928, 12 pages
http://dx.doi.org/10.1155/2011/707928
Research Article

Liver GlucokinaseA456V Induces Potent Hypoglycemia without Dyslipidemia through a Paradoxical Induction of the Catalytic Subunit of Glucose-6-Phosphatase

Biophysics Unit, Department of Physiological Sciences II, IDIBELL-University of Barcelona, Campus de Bellvitge, 08907 L'Hospitalet de Llobregat, Spain

Received 4 August 2011; Accepted 9 September 2011

Academic Editor: Maria L. Dufau

Copyright © 2011 Anna Vidal-Alabró et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. L. Jetton, Y. Liang, C. C. Pettepher et al., “Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut,” Journal of Biological Chemistry, vol. 269, no. 5, pp. 3641–3654, 1994. View at Google Scholar · View at Scopus
  2. F. C. Schuit, P. Huypens, H. Heimberg, and D. G. Pipeleers, “Glucose sensing in pancreatic β-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus,” Diabetes, vol. 50, no. 1, pp. 1–11, 2001. View at Google Scholar · View at Scopus
  3. D. Zelent, M. L. Golson, B. Koeberlein et al., “A glucose sensor role for glucokinase in anterior pituitary cells,” Diabetes, vol. 55, no. 7, pp. 1923–1929, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Van Schaftingen, A. Vandercammen, M. Detheux, and D. R. Davies, “The regulatory protein of liver glucokinase,” Advances in Enzyme Regulation, vol. 32, pp. 133–148, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Alvarez, I. Roncero, J. A. Chowen, P. Vázquez, and E. Blázquez, “Evidence that glucokinase regulatory protein is expressed and interacts with glucokinase in rat brain,” Journal of Neurochemistry, vol. 80, no. 1, pp. 45–53, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. V. V. Heredia, T. J. Carlson, E. Garcia, and S. Sun, “Biochemical basis of glucokinase activation and the regulation by glucokinase regulatory protein in naturally occurring mutations,” Journal of Biological Chemistry, vol. 281, no. 52, pp. 40201–40207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. F. M. Matschinsky, “Assessing the potential of glucokinase activators in diabetes therapy,” Nature Reviews Drug Discovery, vol. 8, no. 5, pp. 399–416, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Grimsby, R. Sarabu, W. L. Corbett et al., “Allosteric activators of glucokinase: potential role in diabetes therapy,” Science, vol. 301, no. 5631, pp. 370–373, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. A. M. Efanov, D. G. Barrett, M. B. Brenner et al., “A novel glucokinase activator modulates pancreatic islet and hepatocyte function,” Endocrinology, vol. 146, no. 9, pp. 3696–3701, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Leighton, A. Atkinson, and M. P. Coghlan, “Small molecule glucokinase activators as novel anti-diabetic agents,” Biochemical Society Transactions, vol. 33, no. 2, pp. 371–374, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. K. J. Brocklehurst, V. A. Payne, R. A. Davies et al., “Stimulation of hepatocyte glucose metabolism by novel small molecule glucokinase activators,” Diabetes, vol. 53, no. 3, pp. 535–541, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Futamura, H. Hosaka, A. Kadotani et al., “An allosteric activator of glucokinase impairs the interaction of glucokinase and glucokinase regulatory protein and regulates glucose metabolism,” Journal of Biological Chemistry, vol. 281, no. 49, pp. 37668–37674, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. N. L. Beer, N. D. Tribble, L. J. McCulloch et al., “The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver,” Human Molecular Genetics, vol. 18, no. 21, pp. 4081–4088, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Vaxillaire, C. Cavalcanti-Proença, A. Dechaume et al., “The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general french population,” Diabetes, vol. 57, no. 8, pp. 2253–2257, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Niwa, K. Yamamura, and J. Miyazaki, “Efficient selection for high-expression transfectants with a novel eukaryotic vector,” Gene, vol. 108, no. 2, pp. 193–200, 1991. View at Publisher · View at Google Scholar · View at Scopus
  16. Z. Y. Chen, C. Y. He, L. Meuse, and M. A. Kay, “Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo,” Gene Therapy, vol. 11, no. 10, pp. 856–864, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. Z.-Y. Chen, S. R. Yant, C.-Y. He, L. Meuse, S. Shen, and M. A. Kay, “Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver,” Molecular Therapy, vol. 3, no. 3, pp. 403–410, 2001. View at Publisher · View at Google Scholar
  18. Y. K. Song, F. Liu, G. Zhang, and D. Liu, “Hydrodynamics-based transfection: simple and efficient method for introducing and expressing transgenes in animals by intravenous injection of DNA,” Methods in Enzymology, vol. 346, Article ID 5, pp. 92–105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. A. L. Davidson and W. J. Arion, “Factors underlying significant underestimations of glucokinase activity in crude liver extracts: physiological implications of higher cellular activity,” Archives of Biochemistry and Biophysics, vol. 253, no. 1, pp. 156–167, 1987. View at Google Scholar · View at Scopus
  20. S. R. Pekovich, P. R. Martin, and C. K. Singleton, “Thiamine pyrophosphate-requiring enzymes are altered during pyrithiamine-induced thiamine deficiency in cultured human lymphoblasts,” Journal of Nutrition, vol. 126, no. 7, pp. 1791–1798, 1996. View at Google Scholar · View at Scopus
  21. E. Van Schaftingen, B. Lederer, R. Bartrons, and H. G. Hers, “A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate,” European Journal of Biochemistry, vol. 129, no. 1, pp. 191–195, 1982. View at Google Scholar · View at Scopus
  22. P. Hakimi, M. T. Johnson, J. Yang et al., “Phosphoenolpyruvate carboxykinase and the critical role of cataplerosis in the control of hepatic metabolism,” Nutrition and Metabolism, vol. 2, article no. 33, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. A. G. Gómez-Valadés, A. Vidal-Alabró, M. Molas et al., “Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi,” Molecular Therapy, vol. 13, no. 2, pp. 401–410, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. V. G. Budker, V. M. Subbotin, T. Budker, M. G. Sebestyén, G. Zhang, and J. A. Wolff, “Mechanism of plasmid delivery by hydrodynamic tain vein injection. II. Morphological studies,” Journal of Gene Medicine, vol. 8, no. 7, pp. 874–888, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Kietzmann, U. Roth, S. Freimann, and K. Jungermann, “Arterial oxygen partial pressures reduce the insulin-dependent induction of the perivenously located glucokinase in rat hepatocyte cultures: mimicry of arterial oxygen pressures by H2O2,” Biochemical Journal, vol. 321, no. 1, pp. 17–20, 1997. View at Google Scholar · View at Scopus
  26. D. Bosco, P. Meda, and P. B. Iynedjian, “Glucokinase and glucokinase regulatory protein: mutual dependence for nuclear localization,” Biochemical Journal, vol. 348, no. 1, pp. 215–222, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. N. De La Iglesia, M. Mukhtar, J. Seoane, J. J. Guinovart, and L. Agius, “The role of the regulatory protein of glucokinase in the glucose sensory mechanism of the hepatocyte,” Journal of Biological Chemistry, vol. 275, no. 14, pp. 10597–10603, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. M. F. Pino, K. A. Kim, K. D. Shelton et al., “Glucokinase thermolability and hepatic regulatory protein binding are essential factors for predicting the blood glucose phenotype of missense mutations,” Journal of Biological Chemistry, vol. 282, no. 18, pp. 13906–13916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. M. O'Doherty, D. L. Lehman, S. Télémaque-Potts, and C. B. Newgard, “Metabolic impact of glucokinase overexpression in liver: lowering of blood glucose in fed rats is accompanied by hyperlipidemia,” Diabetes, vol. 48, no. 10, pp. 2022–2027, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Ferre, A. Pujol, E. Riu, F. Bosch, and A. Valera, “Correction of diabetic alterations by glucokinase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 14, pp. 7225–7230, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Morral, “Gene therapy for type 1 diabetes: new approaches,” Minerva Medica, vol. 95, no. 2, pp. 93–104, 2004. View at Google Scholar · View at Scopus
  32. T. Ferre, E. Riu, S. Franckhauser, J. Agudo, and F. Bosch, “Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance,” Diabetologia, vol. 46, no. 12, pp. 1662–1668, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. N. Morral, R. McEvoy, H. Dong et al., “Adenovirus-mediated expression of glucokinase in the liver as an adjuvant treatment for type 1 diabetes,” Human Gene Therapy, vol. 13, no. 13, pp. 1561–1570, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Massillon, “Regulation of the glucose-6-phosphatase gene by glucose occurs by transcriptional and post-transcriptional mechanisms. Differential effect of glucose and xylitol,” Journal of Biological Chemistry, vol. 276, no. 6, pp. 4055–4062, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. D. Massillon, W. Chen, N. Barzilai et al., “Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats,” Journal of Biological Chemistry, vol. 273, no. 1, pp. 228–234, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. C. Wu, D. A. Okar, C. B. Newgard, and A. J. Lange, “Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in mouse liver lowers blood glucose by suppressing hepatic glucose production,” Journal of Clinical Investigation, vol. 107, no. 1, pp. 91–98, 2001. View at Google Scholar · View at Scopus
  37. D. Farrelly, K. S. Brown, A. Tieman et al., “Mice mutant for glucokinase regulatory protein exhibit decreased liver glucokinase: a sequestration mechanism in metabolic regulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 25, pp. 14511–14516, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Grimsby, J. W. Coffey, M. T. Dvorozniak et al., “Characterization of glucokinase regulatory protein-deficient mice,” Journal of Biological Chemistry, vol. 275, no. 11, pp. 7826–7831, 2000. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Kamata, M. Mitsuya, T. Nishimura, J. I. Eiki, and Y. Nagata, “Structural basis for allosteric regulation of the monomeric allosteric enzyme human glucokinase,” Structure, vol. 12, no. 3, pp. 429–438, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Morral, H. J. Edenberg, S. R. Witting, J. Altomonte, T. Chu, and M. Brown, “Effects of glucose metabolism on the regulation of genes of fatty acid synthesis and triglyceride secretion in the liver,” Journal of Lipid Research, vol. 48, no. 7, pp. 1499–1510, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Lefesvre, J. Attema, A. Lemckert, M. Havenga, and D. van Bekkum, “Genetic heterogeneity in response to adenovirus gene therapy,” BMC Molecular Biology, vol. 4, article no. 4, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. R. J. Noel, Prospects for Genetic Manipulation in Diabetes, Elsevier, Amsterdam, The Netherlands, 1996.
  43. T. Matsuzaka, H. Shimano, N. Yahagi et al., “Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated mice,” Diabetes, vol. 53, no. 3, pp. 560–569, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Sparsø, G. Andersen, T. Nielsen et al., “The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes,” Diabetologia, vol. 51, no. 1, pp. 70–75, 2008. View at Publisher · View at Google Scholar
  45. J. An, Y. Li, G. Van De Werve, and C. B. Newgard, “Overexpression of the P46 (T1) translocase component of the glucose-6-phosphatase complex in hepatocytes impairs glycogen accumulation via hydrolysis of glucose 1-phosphate,” Journal of Biological Chemistry, vol. 276, no. 14, pp. 10722–10729, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Seoane, K. Trinh, R. M. O'Doherty et al., “Metabolic impact of adenovirus-mediated overexpression of the glucose- 6-phosphatase catalytic subunit in hepatocytes,” Journal of Biological Chemistry, vol. 272, no. 43, pp. 26972–26977, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Aiston, K. Y. Trinh, A. J. Lange, C. B. Newgard, and L. Agius, “Glucose-6-phosphatase overexpression lowers glucose 6-phosphate and inhibits glycogen synthesis and glycolysis in hepatocytes without affecting glucokinase translocation. Evidence against feedback inhibition of glucokinase,” Journal of Biological Chemistry, vol. 274, no. 35, pp. 24559–24566, 1999. View at Publisher · View at Google Scholar · View at Scopus
  48. K. Y. Trinh, R. M. O'Doherty, P. Anderson, A. J. Lange, and C. B. Newgard, “Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats,” Journal of Biological Chemistry, vol. 273, no. 47, pp. 31615–31620, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Van De Werve, A. Lange, C. Newgard, M. C. Méchin, Y. Li, and A. Berteloot, “New lessons in the regulation of glucose metabolism taught by the glucose 6-phosphatase system,” European Journal of Biochemistry, vol. 267, no. 6, pp. 1533–1549, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. D. K. Scott, J. J. Collier, T. T. T. Doan et al., “A modest glucokinase overexpression in the liver promotes fed expression levels of glycolytic and lipogenic enzyme genes in the fasted state without altering SREBP-1c expression,” Molecular and Cellular Biochemistry, vol. 254, no. 1-2, pp. 327–337, 2003. View at Publisher · View at Google Scholar · View at Scopus
  51. N. Rideau, M. Derouet, J. Grimsby, and J. Simon, “Glucokinase activation induces potent hypoglycemia without recruiting insulin and inhibits food intake in chicken,” General and Comparative Endocrinology, vol. 169, no. 3, pp. 276–283, 2010. View at Publisher · View at Google Scholar · View at Scopus